Clinical Trial Update: STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

View source ↗

Summary

The STRIDE study evaluating AT-GAA in patients with late-onset Pompe disease who are on enzyme replacement therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Pompe Disease

Drugs mentioned

• AT-GAA

Snippet

Sponsor: Amicus Therapeutics | Conditions: Late-onset Pompe Disease | Status: TERMINATED